Lincoln Pharmaceuticals Ltd.
NSE: LINCOLN | BSE: 531633
₹678.90
₹34.70
(5.39%)
As on 18-May-2026 15:42IST
Market cap
₹1,260 Cr
Revenue (TTM)
₹652 Cr
P/E Ratio
14.3
P/B Ratio
1.7
Div. Yield
0.3 %
Quality Score
9/10
Growth Score
7/10
Valuation Score
6/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹88 Cr
-
ROE
13 %
-
ROCE
17.6 %
-
Industry P/E
31.55
-
EV/EBITDA
9.5
-
Debt to Equity
0
-
Book Value
₹371.6
-
EPS
₹43.9
-
Face value
10
-
Shares outstanding
20,029,728
10 Years Aggregate
CFO
₹565.63 Cr
EBITDA
₹745.62 Cr
Net Profit
₹566.94 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lincoln Pharma
| 40.3 | 15.6 | 10.3 | 13.3 | 16.5 | 16.3 | 16.0 |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lincoln Pharma
| -43.5 | 22.8 | 71.4 | -0.8 | 47.3 | 18.7 | -9.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lincoln Pharma
|
678.9 | 1,260.0 | 651.9 | 87.8 | 13.1 | 12.7 | 14.3 | 1.7 |
| 3,214.1 | 40,160.6 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 38 | 8.9 | |
| 8,513.5 | 21,376.1 | 2,177.5 | 200.9 | 11.3 | 26.5 | 106.4 | 25.7 | |
| 1,986.1 | 15,149.1 | 2,187.2 | 649.7 | 31.5 | 19 | 23.6 | 4.2 | |
| 1,340.8 | 18,658.1 | 3,078.2 | 469.4 | 26.4 | 14.9 | 43.2 | 5.1 | |
| 2,125.3 | 34,258.4 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.3 | 8.2 | |
| 4,859.3 | 22,306.4 | 2,519.7 | 722.4 | 33.6 | 18.8 | 30.9 | 5.3 | |
| 5,255.0 | 8,697.6 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29.6 | 12.5 | |
| 476.2 | 9,372.3 | 1,432.0 | 149.0 | 19.1 | 7.9 | 62.5 | 3.8 | |
| 1,151.4 | 10,540.9 | 4,725.6 | 528.7 | 14.9 | 20.7 | 20.6 | 3.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Lincoln Pharma
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal,... corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. The company was incorporated in 1979 and is based in Ahmedabad, India. Read more
-
Incorporated
1995
-
Chairman
Kishor M Shah
-
Managing Director
Mahendra G Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Lincoln Pharma
What is the current share price of Lincoln Pharmaceuticals Ltd Today?
The share price of Lincoln Pharmaceuticals Ltd is ₹678.90 (NSE) and ₹690.00 (BSE) as of 18-May-2026 15:42 IST. Lincoln Pharmaceuticals Ltd has given a return of 16.45% in the last 3 years.
What is the current PB & PE ratio of Lincoln Pharmaceuticals Ltd?
The P/E ratio of Lincoln Pharmaceuticals Ltd is 14.34 times as on 18-May-2026, a 55 discount to its peers’ median range of 31.55 times.
The P/B ratio of Lincoln Pharmaceuticals Ltd is 1.69 times as on 18-May-2026, a 63 discount to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.42
|
1.64
|
|
2024
|
12.57
|
1.98
|
|
2023
|
9.31
|
1.35
|
|
2022
|
8.98
|
1.44
|
|
2021
|
7.23
|
1.23
|
What is the 52 Week High and Low of Lincoln Pharmaceuticals Ltd?
The 52-week high and low of Lincoln Pharmaceuticals Ltd are Rs 733.00 and Rs 440.00 as of 18-May-2026.
What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of ₹ 1,260 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Lincoln Pharmaceuticals Ltd?
Before investing in Lincoln Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.